High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9.3M
$9,324,784
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $1,557 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $15,786 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $15,779 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $1,575 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $5,506 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $5,442 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $8,640 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $7,836 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $1,565 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $1,562 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $2,342 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $7,060 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $3,898 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $162,146 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $3,160 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $43,994 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $125,512 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Zoghbi Huda Y
• Director
10b5-1 SellΔOwn -10.3%
2026-02-19
$172,324
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -10.3%
|
2026-02-19 | $172,324 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Zoghbi Huda Y
• Director
10b5-1 SellΔOwn -12.2%
2026-02-19
$233,066
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -12.2%
|
2026-02-19 | $233,066 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $163,288 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Zoghbi Huda Y
• Director
10b5-1 SellΔOwn -11.1%
2026-02-19
$258,329
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -11.1%
|
2026-02-19 | $258,329 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Other
|
2026-02-19 | $617,018 | M | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $37,959 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $38,775 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $41,259 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$785
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $785 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $776 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $7,766 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $44,321 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $9,342 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $3,897 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $780 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $3,907 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $783 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $2,350 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $785 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $786 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $1,573 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $788 | S | Form 4 |
|
REGN
M
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
Other
2026-02-09
$492,000
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
Other
|
2026-02-09 | $492,000 | M | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$15,519
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $15,519 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$404,520
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $404,520 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$304,006
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $304,006 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 SellΔOwn -10.5%
2026-02-09
$438,211
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 SellΔOwn -10.5%
|
2026-02-09 | $438,211 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$159,810
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $159,810 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$58,504
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $58,504 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$20,316
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $20,316 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$28,959
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $28,959 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$112,785
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $112,785 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • SVP Controller
10b5-1 Sell
2026-02-09
$41,643
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • SVP Controller
10b5-1 Sell
|
2026-02-09 | $41,643 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Other
|
2026-01-07 | $561,180 | M | Form 4 |
|
REGN
M
REGENERON PHARMACEUTICALS, INC.
Bassler Bonnie L
• Director
Equity Compensation
2026-01-07
$0
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Bassler Bonnie L
• Director
10b5-1 SellΔOwn -46.8%
2026-01-07
$1,200,000Large
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -46.8%
|
2026-01-07 | $1,200,000Large | S | Form 4 |
|
REGN
M
REGENERON PHARMACEUTICALS, INC.
YANCOPOULOS GEORGE
• President
Equity Compensation
2025-12-09
$0
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
President
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-12-09 | $95,976,989MEGA | M | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
|
REGN
M
REGENERON PHARMACEUTICALS, INC.
YANCOPOULOS GEORGE
• President
Other
2025-12-09
$81,580,691MEGA
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
President
Other
|
2025-12-09 | $81,580,691MEGA | M | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Bassler Bonnie L
• Director
10b5-1 SellΔOwn -32.9%
2025-11-20
$570,000
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -32.9%
|
2025-11-20 | $570,000 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Other
|
2025-11-20 | $282,264 | M | Form 4 |
|
REGN
M
REGENERON PHARMACEUTICALS, INC.
LAROSA JOSEPH J
• Officer • EVP General Counsel and Secret
Other
2025-11-20
$8,029,431Whale
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • EVP General Counsel and Secret
Other
|
2025-11-20 | $8,029,431Whale | M | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Pitofsky Jason
• Officer • VP Controller
Discretionary Sell
2025-11-07
$280,766
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • VP Controller
Discretionary Sell
|
2025-11-07 | $280,766 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Other
|
2025-10-30 | $1,410,267Large | M | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Other
|
2025-10-29 | $3,380,065Large | M | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
POON CHRISTINE A
• Director
Discretionary Sell
2025-10-29
$424,242
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Discretionary Sell
|
2025-10-29 | $424,242 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
POON CHRISTINE A
• Director
Discretionary SellΔOwn -33.4%
2025-10-29
$1,787,322Large
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -33.4%
|
2025-10-29 | $1,787,322Large | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
POON CHRISTINE A
• Director
Discretionary SellΔOwn -35.0%
2025-10-29
$1,253,214Large
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -35.0%
|
2025-10-29 | $1,253,214Large | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
POON CHRISTINE A
• Director
Discretionary Sell
2025-10-29
$65,510
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Discretionary Sell
|
2025-10-29 | $65,510 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
POON CHRISTINE A
• Director
Discretionary SellΔOwn -20.6%
2025-10-29
$467,428
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -20.6%
|
2025-10-29 | $467,428 | S | Form 4 |
|
REGN
M
REGENERON PHARMACEUTICALS, INC.
MURPHY ANDREW J
• Officer • EVP Research
Other
2025-10-29
$19,448,450MEGA
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Officer • EVP Research
Other
|
2025-10-29 | $19,448,450MEGA | M | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
POON CHRISTINE A
• Director
Discretionary SellΔOwn -14.2%
2025-10-29
$255,029
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -14.2%
|
2025-10-29 | $255,029 | S | Form 4 |